SOW
CAPR icon

State of Wyoming’s Capricor Therapeutics CAPR Stock Holding History

State of Wyoming’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.1K Buy
1,252
+453
+57% +$13.7K ﹤0.01% 1761
2026
Q1 		$24.3K Sell
799
-3,630
-82% -$96.7K ﹤0.01% 1658
2025
Q4 		$128K Buy
4,429
+1,913
+76% +$25K 0.01% 1221
2025
Q3 		$18.1K Buy
2,516
+300
+14% +$2.21K ﹤0.01% 1715
2025
Q2 		$22K Buy
+2,216
New +$23.4K ﹤0.01% 1698

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State of Wyoming's CAPR Position: Q2 2026 in Review

State of Wyoming increased its Capricor Therapeutics (CAPR) stake by 57% in Q2 2026, buying an estimated $13.7K and bringing the position to 1,252 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1761.

State of Wyoming first reported a position in CAPR in Q2 2025 and has held it in 5 quarters since. The position peaked at $128K in Q4 2025. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • State of Wyoming held 1,252 shares of Capricor Therapeutics worth $30.1K as of Q2 2026.
  • State of Wyoming bought 453 Capricor Therapeutics shares in Q2 2026, an estimated $13.7K.
  • Capricor Therapeutics made up ﹤0.01% of State of Wyoming's portfolio in Q2 2026, its #1761 holding.
  • State of Wyoming first reported a position in Capricor Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • State of Wyoming's Capricor Therapeutics position peaked at $128K in Q4 2025.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.